Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression
- 17 March 2010
- journal article
- Published by Elsevier BV in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 34 (2), 279-283
- https://doi.org/10.1016/j.pnpbp.2009.11.018
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Targeting glial physiology and glutamate cycling in the treatment of depressionBiochemical Pharmacology, 2009
- Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depressionProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2008
- Defective group-II metaboropic glutamate receptors in the hippocampus of spontaneously depressed ratsNeuropharmacology, 2008
- Elevated levels of NR2A and PSD-95 in the lateral amygdala in depressionInternational Journal of Neuropsychopharmacology, 2008
- Targeting the glutamatergic system to develop novel, improved therapeutics for mood disordersNature Reviews Drug Discovery, 2008
- Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugsPharmacology & Therapeutics, 2007
- Elevated Levels of the NR2C Subunit of the NMDA Receptor in the Locus Coeruleus in DepressionNeuropsychopharmacology, 2005
- Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjectsMolecular Psychiatry, 2002
- LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptorsNeuropharmacology, 1998
- NOSOLOGY OF CHRONIC MOOD DISORDERSPsychiatric Clinics of North America, 1996